Varshney, Dhaval
Cuesta, Sergio Martinez
Herdy, Barbara
Abdullah, Ummi Binti
Tannahill, David
Balasubramanian, Shankar
Funding for this research was provided by:
Herchel Smith Funds
Wellcome Trust
Cancer Research UK
Article History
Received: 2 July 2021
Accepted: 27 October 2021
First Online: 23 November 2021
Competing interests
: S.B. is a founder and shareholder of Cambridge Epigenetix Ltd. No competing interests declared by remaining authors.